Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of NCTX in Healthy Volunteers
NCT02063594Phase 1Terminated
- Sponsor
- Marval Pharma Ltd.
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing NCTX with Saline Placebo (2 arms). Primary endpoint: Assessment of safety by clinical laboratory parameters, vital sign measurements, electrocardiograms, and adverse event monitoring at 28 days. Started Mar 2014; status: terminated.
02
Drugs
NCTX
Beyond the preview
Go deeper on NCT02063594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02063594.